The following table summarizes the non-vested restricted stock units outstanding as of September 26, 2026 (in thousands, except per unit data):


	Number Of RSUs	Weighted Average Grant Date Fair Value
Outstanding as of March 28, 2026	202	$	81.36
Granted	88	$	79.46
Vested	21	$	74.84
Forfeited	16	$	86.74
Outstanding as of September 26, 2026	253	$	80.38

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $2.2 million and $4.2 million for the three and six months ended September 26, 2026, respectively. The expense related to restricted stock units for the three and six months ended September 27, 2025 was $1.8 million and $2.5 million, respectively. As of September 26, 2026, unearned compensation, to be recognized over the grants’ respective service periods, totaled $12.8 million based on estimated achievement levels as of September 26, 2026. If the maximum performance levels were achieved, the unearned compensation could be as much as $14.8 million.

Stock Options: There were no stock option grants for the first six months of fiscal year 2027. The following weighted-average assumptions were used to value options granted during the first six months of fiscal year 2026:


	Second Quarter Ended		Six Months Ended
	September 27, 2025		September 27, 2025

Risk-Free Interest Rate	3.93	%	3.89	%
Volatility Factor	46.71	%	46.78	%
Expected Term (in Years)	4		4
Annual Dividend Rate	—	%	—	%

The expense related to all stock option awards was less than $0.1 million and $0.1 million for the three and six months ended September 26, 2026, respectively. Total expense related to all stock option awards for the three and six months ended September 27, 2025 was $0.2 million and $0.4 million, respectively.

The following table summarizes the Company’s options as of and for the first six months ended September 26, 2026 (in thousands, except price per option data and years):


	Number Of Options	Weighted Average Exercise Price Per Option		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding as of March 28, 2026	177	$	72.42
Granted	-	$	—
Exercised	(34)	$	53.23
Forfeited	(5)	$	115.24
Expired	(4)	$	62.40
Outstanding as of September 26, 2026	134	$	83.49	4	$	2,456
Exercisable as of September 26, 2026	107	$	70.25	4	$	2,034

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the second quarter of fiscal year 2027 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on September 26, 2026. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.